查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1383635

马人工授精市场 - 全球产业规模、份额、趋势、机会和预测，2018-2028 年按解决方案、马类型、配销通路、地区、竞争预测和机会细分，2018-2028F

Equine Artificial Insemination Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Solution, By Equine Type, By Distribution Channel, By Region, By Competition Forecast & Opportunities, 2018-2028F
出版日期: | 出版商: TechSci Research | 英文 175 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022 年，全球马人工授精市场价值为 6.143 亿美元，预计在预测期内将出现令人印象深刻的成长，到 2028 年复合CAGR为5.66%。由于几个关键因素，该市场正在见证成长。其中包括新兴经济体采用传统精液、马匹育种对人工授精技术的需求不断增长，以及不断提高动物生产力和效率。此外，在已开发国家和发展中国家，有利的促销活动、兽医数量的增加以及提供人工授精手术的医院数量的增加正在推动市场扩张。

主要市场驱动因素

遗传改良：增强马的特性

市场概况
预测期 2024-2028
2022 年市场规模 61430万美元
2028 年市场规模 8.5135亿美元
2023-2028 年CAGR 5.66%
成长最快的细分市场 私人的
最大的市场 北美洲

在对马的优良遗传性状的追求的推动下，马匹育种领域正在经历一场变革。这种追求卓越的动力刺激了全球马人工授精市场的快速成长，饲养者和爱好者转向先进的生殖技术来增强和完善马匹伴侣的基因组成。马匹爱好者和饲养员长期以来一直对繁殖艺术和对马匹卓越性的追求着迷。马经过几代人的选择性培育，以满足从敏捷性和速度到气质和体形的各种目标。然而，传统的自然交配方法有其限制。种马和母马必须亲自到场，这个过程对动物和饲养员来说都是不可预测的和危险的。人工授精最显着的优点之一是能够从精英种公身上获取遗传物质，而不受地理限制。这意味着繁殖者可以利用世界各地着名种马的遗传潜力。它允许地球某个角落的母马用另一侧冠军种马的精液进行授精，从而提供更广泛的基因库，并有机会将理想的性状引入血统中。人工授精可以对繁殖过程进行细緻的控制。繁殖者可以仔细选择具有特定特征的种马，他们希望将这些特征遗传给后代，无论是速度、耐力、敏捷性或气质。这种性状选择的精确度从根本上改变了育种格局，使育种者能够创造出在特定学科中表现出色的血统，无论是赛马、障碍赛、盛装舞步还是主力马。遗传改良的另一个重要面向是保留马匹族群内的遗传多样性。由于某些马品种面临近亲繁殖导致遗传变异性降低的威胁，人工授精提供了一种引入新鲜遗传物质并减轻与有限基因库相关的风险的方法。这有助于维持马群的整体健康和活力。人工授精也加快了遗传进展的速度。传统的育种方法可能非常耗时，而且结果往往不确定。透过人工授精，繁殖者可以在一个繁殖季节从同一匹种马中产生多个后代，从而增加了产生特殊个体的机会，从而提高了品种的品质和性能。无论是竞技运动、休閒骑马或其他马术活动，市场对高品质、基因优越的马匹的需求正在增加。饲养者认识到生产满足这些市场需求的马匹的重要性，而人工授精是实现这一目标不可或缺的工具。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球马人工授精市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依解决方案（设备和消耗品、精液（正常精液、性控精液）、服务）
    • 依马匹类型（运动/竞赛、休閒、其他）
    • 按配销通路（私人、公共）
    • 按地区
    • 按公司划分 (2022)
  • 产品市场地图
    • 按解决方案
    • 按马匹类型
    • 按配销通路
    • 按地区

第 6 章：北美马人工授精市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依解决方案（设备和消耗品、精液（正常精液、性控精液）、服务）
    • 依马匹类型（运动/竞赛、休閒、其他）
    • 按配销通路（私人、公共）
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲马人工授精市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依解决方案（设备和消耗品、精液（正常精液、性控精液）、服务）
    • 依马匹类型（运动/竞赛、休閒、其他）
    • 按配销通路（私人、公共）
    • 按国家/地区
  • 欧洲：国家分析
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙

第 8 章：亚太马人工授精市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依解决方案（设备和消耗品、精液（正常精液、性控精液）、服务）
    • 依马匹类型（运动/竞赛、休閒、其他）
    • 按配销通路（私人、公共）
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国

第 9 章：南美洲马人工授精市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依解决方案（设备和消耗品、精液（正常精液、性控精液）、服务）
    • 依马匹类型（运动/竞赛、休閒、其他）
    • 按配销通路（私人、公共）
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第10章：中东和非洲马人工授精市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依解决方案（设备和消耗品、精液（正常精液、性控精液）、服务）
    • 依马匹类型（运动/竞赛、休閒、其他）
    • 按配销通路（私人、公共）
    • 按国家/地区
  • MEA：国家分析
    • 南非马人工授精
    • 沙乌地阿拉伯马人工授精
    • 阿联酋马人工授精
    • 科威特马人工授精

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第14章：竞争格局

  • 商业概览
  • 产品供应
  • 最近的发展
  • 财务（据报导）
  • 主要人员
  • SWOT分析
    • IMV Technologies SADIR
    • Stallion AI Services Ltd
    • Zoetis Inc
    • Neogen Corp
    • Zerlotti Genetics Ltd
    • Erc Sro
    • CVS UK Ltd
    • HOFFMAN AI BREEDERS INC.
    • Continental Genetics, LLC
    • Minitub GmbH

第 15 章：策略建议

第 16 章：关于我们与免责声明

简介目录
Product Code: 17484

Global Equine Artificial Insemination Market has valued at USD 614.30 million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.66% through 2028. The market is witnessing growth due to several key factors. These include the adoption of conventional semen in emerging economies, a growing demand for artificial insemination techniques in horse breeding, and the continuous drive to enhance animal productivity and efficiency. Furthermore, market expansion is being driven by favorable promotional campaigns, a rising number of veterinarians, and an increasing number of hospitals offering artificial insemination procedures, both in developed and developing nations.

Key Market Drivers

Genetic Improvement: Enhancing Equine Traits

Market Overview
Forecast Period2024-2028
Market Size 2022USD 614.30 Million
Market Size 2028USD 851.35 Million
CAGR 2023-20285.66%
Fastest Growing SegmentPrivate
Largest MarketNorth America

The world of equine breeding is undergoing a transformative shift, driven by the quest for superior genetic traits in horses. This drive for excellence has spurred the rapid growth of the Global Equine Artificial Insemination Market, as breeders and enthusiasts turn to advanced reproductive technologies to enhance and refine the genetic makeup of their equine companions. Equine enthusiasts and breeders have long held a fascination with the art of breeding and the quest for equine excellence. Horses have been selectively bred for generations to meet various objectives, from agility and speed to temperament and conformation. However, the traditional methods of natural mating have limitations. Stallions and mares must be physically present, and the process can be unpredictable and risky for both the animals and handlers. One of the most significant advantages of artificial insemination is the ability to access genetic material from elite sires, regardless of geographical constraints. This means that breeders can tap into the genetic potential of renowned stallions from around the world. It allows for a mare in one corner of the globe to be inseminated with semen from a champion stallion located on the opposite side, offering a broader gene pool and an opportunity to introduce desirable traits into the lineage. Artificial insemination allows for meticulous control over the breeding process. Breeders can carefully select stallions with specific traits they want to pass on to the offspring, be it speed, endurance, agility, or temperament. This level of precision in trait selection has fundamentally altered the breeding landscape, enabling breeders to create lineages that excel in specific disciplines, whether it's racing, show jumping, dressage, or workhorses. Another critical aspect of genetic improvement is the preservation of genetic diversity within equine populations. As certain horse breeds face the threat of reduced genetic variability due to inbreeding, artificial insemination provides a way to introduce fresh genetic material and mitigate the risks associated with a limited gene pool. This helps maintain the overall health and vitality of equine populations. Artificial insemination also accelerates the rate of genetic progress. Traditional breeding methods can be time-consuming, and the outcome is often uncertain. With artificial insemination, breeders can produce multiple offspring from the same stallion in a single breeding season, increasing the chances of producing exceptional individuals that advance the breed's quality and performance. The market demand for high-quality, genetically superior horses is on the rise, whether it's for competitive sports, leisure riding, or other equine activities. Breeders recognize the importance of producing horses that meet these market demands, and artificial insemination is an indispensable tool in achieving this goal.

Health and Safety: Mitigating Risks in Horse Breeding

Horse breeding has been an age-old tradition, but the landscape is evolving, and with it comes a heightened focus on safety and the welfare of both the horses and the handlers involved. This paradigm shift has led to a surge in the adoption of artificial insemination techniques, which are not only reshaping the equine industry but also driving the growth of the Global Equine Artificial Insemination Market. Traditionally, natural mating has been the standard method for breeding horses. While it may have a certain romantic allure, it's not without risks. Stallions and mares can be unpredictable during mating, leading to injuries and even fatalities for both animals and their handlers. This has prompted a growing concern for the safety and well-being of those involved in equine breeding. Artificial insemination provides a controlled and safer environment for equine breeding. The process eliminates the need for direct physical contact between the stallion and the mare, significantly reducing the risk of injury. This safety aspect is particularly important when dealing with high-value or high-strung horses, as well as when working with inexperienced or anxious handlers. In addition to physical safety, artificial insemination also helps reduce the risk of disease transmission. Natural mating can potentially facilitate the spread of contagious diseases between horses. Artificial insemination, on the other hand, involves a carefully managed process that minimizes the chances of disease transmission, safeguarding the health of the animals involved and preventing outbreaks that could devastate entire equine populations. Artificial insemination allows breeders to have greater control over the breeding process. It enables precise timing of insemination, optimizing the chances of conception. This level of control is particularly valuable when dealing with mares that may have irregular estrous cycles or reproductive issues. It also helps maximize the use of valuable breeding seasons, especially in the case of high-demand stallions. Artificial insemination is accessible and convenient, making it an attractive option for breeders of all levels of expertise. Technology has become more readily available, and the training required for artificial insemination is accessible through educational programs and veterinary services. This accessibility has encouraged more breeders to adopt artificial insemination as a safer and more reliable breeding method. As the equine industry becomes increasingly regulated, with a strong emphasis on animal welfare, artificial insemination aligns with these evolving standards. Breed associations and regulatory bodies often have guidelines in place to ensure the well-being of animals. Artificial insemination, by promoting safety and reducing stress on the horses, is viewed as a more humane and responsible breeding method, which can enhance a breeder's reputation and compliance with industry regulations.

International Trade and Regulation: Meeting Global Standards

The global equine industry is undergoing a transformation, as the demand for high-quality horses transcends borders. With the international trade of horses on the rise, meeting stringent global standards has become imperative. This shift is driving the rapid growth of the Global Equine Artificial Insemination Market, as breeders and enthusiasts turn to advanced reproductive technologies to navigate the complexities of international horse breeding and trade. The trade of horses across international borders has witnessed a remarkable surge in recent years. Horses are transported across the globe for various purposes, including racing, competition, leisure, and work. As a result, breeders and traders must navigate a complex landscape of international regulations and standards, which vary significantly from one country to another. Different countries and regions have distinct standards and regulations governing equine breeding and trade. These standards encompass everything from health and disease control measures to pedigree documentation and genetic traceability. Meeting these standards can be a daunting task, especially when it comes to natural breeding methods, where verifying the lineage and health status of a horse can be challenging. Artificial insemination offers a solution by providing a precise and documented method for breeding. It ensures that genetic lineage is accurately recorded, which is essential for compliance with international breeding standards and for proving the authenticity and quality of the horse being traded.

Artificial insemination allows breeders to access genetic material from stallions located in different regions or even different countries. This accessibility expands the gene pool and opens up opportunities for breeders to introduce desirable traits into their breeding programs. For instance, a mare in one part of the world can be inseminated with semen from a renowned stallion located thousands of miles away, thereby diversifying the genetic makeup of the offspring and increasing its market appeal. The globalization of the equine industry has raised concerns about the transmission of diseases between countries. Natural mating can facilitate disease transmission, as it often requires physical contact between horses. Artificial insemination minimizes this risk by eliminating direct contact between the animals, reducing the chances of disease transmission and promoting biosecurity. Many countries have stringent import and export requirements for horses. These requirements often include health certifications, quarantine periods, and genetic documentation. Artificial insemination aids in meeting these requirements by ensuring that the horse's genetic lineage is well-documented and verifiable. This documentation is essential for obtaining the necessary permits and certifications for international trade. Artificial insemination is viewed favorably by international breed associations and regulatory bodies. Breeders who use artificial insemination are often seen as responsible and compliant with global standards, which can enhance their reputation in the international equine trade community. This reputation can lead to increased demand for their horses and expand their market reach.

Advancements in Reproductive Technologies: Expanding Possibilities

The world of equine breeding is undergoing a revolution, fueled by constant advancements in reproductive technologies. These innovations are not only expanding the possibilities for breeders but also driving remarkable growth in the Global Equine Artificial Insemination Market. The art of breeding horses has evolved significantly over the years, transitioning from traditional natural mating methods to the realm of assisted reproductive technologies. While artificial insemination has long been a valuable tool for breeders, the field is experiencing a surge of innovations that are revolutionizing the way horses are bred and managed. One of the most significant advancements in equine reproductive technology is the technique of embryo transfer. This groundbreaking method allows breeders to multiply the genetic potential of their prized mares and stallions. Instead of relying on a mare to carry a single foal per year, embryo transfer enables the extraction of multiple embryos from the mare's reproductive tract, which can then be implanted into surrogate mares. This innovation dramatically accelerates the rate at which valuable genetics can be propagated. High-performing mares and stallions can produce numerous offspring in a single breeding season, increasing the chances of producing exceptional individuals. Embryo transfer has not only expanded the possibilities for breeders but has also played a pivotal role in fueling the growth of the equine artificial insemination market.

Advancements in reproductive technologies have also had sex selection more feasible and precise. Breeders can now choose the gender of the offspring with greater accuracy, offering significant advantages for both commercial and sport horse breeders. This level of control enables breeders to tailor their breeding programs to meet specific market demands and objectives. Sex selection techniques have not only broadened the range of possibilities in equine breeding but have also increased the attractiveness of artificial insemination as a means to achieve this level of control.

Cryopreservation, the process of freezing and storing equine genetic material (semen and embryos), has seen remarkable improvements. Frozen semen, in particular, has become a valuable resource for breeders, as it can be stored for extended periods while maintaining the viability of the sperm. This development has transformed the global equine breeding landscape by allowing breeders to access the genetic material of renowned stallions even after their natural breeding careers have ended. It has also opened up opportunities for international trade and the expansion of the gene pool.

Modern technology has equipped breeders with sophisticated tools for reproductive monitoring. From ultrasound and hormonal assays to advanced computer-assisted semen analysis, breeders can now closely monitor the reproductive health and fertility of mares and stallions. This level of monitoring ensures that insemination and embryo transfer procedures are performed with the highest chances of success, reducing the costs associated with unsuccessful breeding attempts. The advent of telemedicine has made it easier for breeders to access expert guidance and consultation from reproductive specialists, regardless of their location. This technology enables breeders to seek advice on breeding strategies, monitor reproductive health remotely, and make informed decisions in real-time.

Key Market Challenges

Regulatory Compliance: A Complex Landscape

One of the foremost challenges in the equine artificial insemination market is the complex and varying regulatory landscape. Different countries and regions have their own sets of rules and regulations governing equine breeding practices, including the use of artificial insemination. Compliance with these regulations can be a daunting task, especially for breeders involved in international trade. Navigating these regulatory hurdles is crucial to ensure the legality and acceptance of artificially inseminated horses in various markets.

Equine Reproductive Health Management: A Delicate Balance

Maintaining the reproductive health of mares and stallions is a paramount concern for breeders. Artificial insemination, while reducing certain risks associated with natural mating, still requires meticulous management of reproductive health. Challenges arise in managing the overall reproductive cycle of mares, ensuring proper timing for insemination, and addressing potential complications. This delicate balance can be demanding, especially for breeders dealing with large numbers of mares.

Genetic Diversity Preservation: Striking the Right Balance

While artificial insemination offers the advantage of selecting superior genetic traits, it also poses the risk of reducing genetic diversity within equine populations. Overreliance on a few highly desirable stallions can lead to inbreeding and a loss of genetic variability. Breeders must grapple with this challenge by balancing the pursuit of genetic improvement with the need to preserve genetic diversity, which is essential for the long-term health and vitality of equine populations.

Training and Expertise: Ensuring Quality Assurance

Effective artificial insemination requires specialized knowledge and skills. Training and expertise are paramount for veterinarians and technicians involved in the process. Ensuring that individuals performing artificial insemination are highly skilled and knowledgeable can be a challenge, particularly in regions where such training programs may be limited. Inexperienced or improperly trained personnel can lead to reduced success rates and increased costs.

Key Market Trends

Genetic Selection Precision with Genomic Testing

The trend toward precision breeding is gaining momentum in the equine industry. Genomic testing, which involves analyzing an individual horse's DNA to assess its genetic potential, is becoming more accessible and affordable. Breeders can now use this technology to make data-driven decisions about which stallions and mares to pair, maximizing the likelihood of producing offspring with desired traits. This trend is expected to lead to even more selective breeding and the creation of superior equine bloodlines.

Non-Surgical Insemination Techniques

Advancements in non-surgical insemination techniques are on the horizon. These methods, such as intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF), offer new possibilities for equine breeding. ICSI, for example, allows for the direct injection of a single sperm cell into an egg, offering precise control over the fertilization process. These techniques are likely to gain traction in the equine artificial insemination market, especially for valuable or hard-to-breed mares.

Customized Breeding Programs

The ability to offer customized breeding programs to mare owners is becoming a significant selling point for artificial insemination providers. Breeders and reproductive specialists are tailoring their services to cater to the specific needs and goals of mare owners. This includes offering options such as sex selection, embryo transfer, and comprehensive reproductive health monitoring, allowing mare owners to create a personalized breeding strategy.

International Collaborations and Semen Transport

Globalization in the equine industry is leading to increased international collaborations among breeders. Semen transport services are evolving to meet the demands of breeders who want to access stallions from different regions or countries. Equine artificial insemination providers are expanding their capabilities to ensure the safe and efficient transport of semen across borders, enabling mare owners to access a wider range of genetic material.

Segmental Insights

Solution Insights

Based on the category of Solution, the services sector dominated the market, holding the largest share in 2022. This category encompasses various offerings, including training, synchronization, and artificial insemination. The sector's growth is being fueled by the increasing number of universities offering courses and research programs in horse reproduction. For example, Texas A&M University's Agriculture & Life Science department provides a short course on equine reproductive management tailored for horse owners and breeding managers. This course aims to equip them with effective strategies for ensuring the success of their breeding programs, covering topics such as mare and stallion anatomy and physiology, gestation and foaling, nutrition for broodmares and young horses, estrous cycle management, and mare estrous cycle manipulation.

On the other hand, the semen segment is projected to experience the most rapid growth during the forecast period, with a CAGR. This growth is attributed to the high fertility rates observed in horses. According to My Horse University, a conception rate of 65% is considered the average for horse breeding farms, meaning that 35% of mares that have previously foaled will not become pregnant during the upcoming breeding season. Mare fertility is primarily influenced by age, with a decline typically starting around the age of 12. Fertility significantly impacts the productivity and financial performance of stud farms, necessitating careful evaluation at both the stallion and mare levels, as well as at the scale of the broodmare group and the entire farm. Breeders use semen analysis to monitor changes in semen quality from the time a stallion is acquired until its retirement.

Equine Type Insights

In 2022, the Sports/racing equines category commanded the highest share of revenue and is anticipated to experience the most rapid growth with a CAGR during the forecast period. In contrast to recreational purposes, horses are primarily utilized for activities related to tourism, horse racing, and betting. Globally, warm blood horses are prominent in Olympic sports such as eventing, show jumping, and dressage. Various breeding organizations conduct selection programs specifically for these sport horses, particularly in Europe. These organizations have been engaged in extensive international exchanges of breeding stock for many years. Notably, advancements in reproductive techniques, including the utilization of refrigerated and frozen semen, have enabled breeding stallions to be simultaneously employed in multiple countries. While nations with smaller populations often import breeding stock, those with sizable sport horse populations, like Germany and France, frequently engage in the export of sport horses.

Regional Insights

In 2022, North America took the lead in the market, commanding the largest market share, and it is expected to maintain this dominant position throughout the forecast period. According to data from the Food and Agriculture Organization of the United States, there were approximately 10.56 million horses globally in 2021, with North America alone accounting for 10.96 million of them. Additionally, the proliferation of horse farms and the frequency of horse races have contributed significantly to the market's growth. In the United States, there are more than 300 racetracks, with approximately 33,567 horses participating in these races annually. Furthermore, the import of 18,865 horses into the United States in 2021 has increased the demand for equine artificial insemination (AI) services in North America.

Meanwhile, the Asia Pacific region is poised to experience the swiftest expansion during the forecast period, with China and Japan being the primary driving forces. Japan, in particular, boasts one of the largest horse racing scenes in the world, featuring over 21,000 horse races annually. Although horse racing in Japan has evolved and adopted Western influences, it remains deeply rooted in Japanese culture as a cherished tradition. Currently, all major racing events in Japan are organized by the National Association of Racing (NAR) and the Japan Racing Association (JRA).

Key Market Players

IMV Technologies SADIR

Stallion A I Services Ltd

Zoetis Inc

Neogen Corp

Zerlotti Genetics Ltd

Erc S.r.o.

CVS UK Ltd

HOFFMAN A.I. BREEDERS INC.

Continental Genetics, LLC

Minitub GmbH

Report Scope:

In this report, the Global Equine Artificial Insemination Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Equine Artificial Insemination Market, By Solution:

  • Equipment & Consumables
  • Semen
  • Normal Semen
  • Sexed Semen
  • Services

Equine Artificial Insemination Market, By Equine Type:

  • Sports/Racing
  • Recreation
  • Others

Equine Artificial Insemination Market, By Distribution Channel:

  • Private
  • Public

Equine Artificial Insemination Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Equine Artificial Insemination Market.

Available Customizations:

  • Global Equine Artificial Insemination market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Equine Artificial Insemination Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
    • 5.2.2. By Equine Type (Sports/Racing, Recreation, Others)
    • 5.2.3. By Distribution Channel (Private, Public)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Product Market Map
    • 5.3.1. By Solution
    • 5.3.2. By Equine Type
    • 5.3.3. By Distribution Channel
    • 5.3.4. By Region

6. North America Equine Artificial Insemination Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
    • 6.2.2. By Equine Type (Sports/Racing, Recreation, Others)
    • 6.2.3. By Distribution Channel (Private, Public)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Equine Artificial Insemination Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Solution
        • 6.3.1.2.2. By Equine Type
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Equine Artificial Insemination Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Solution
        • 6.3.2.2.2. By Equine Type
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Equine Artificial Insemination Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Solution
        • 6.3.3.2.2. By Equine Type
        • 6.3.3.2.3. By Distribution Channel

7. Europe Equine Artificial Insemination Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
    • 7.2.2. By Equine Type (Sports/Racing, Recreation, Others)
    • 7.2.3. By Distribution Channel (Private, Public)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Equine Artificial Insemination Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Solution
        • 7.3.1.2.2. By Equine Type
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. United Kingdom Equine Artificial Insemination Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Solution
        • 7.3.2.2.2. By Equine Type
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. France Equine Artificial Insemination Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Solution
        • 7.3.3.2.2. By Equine Type
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Italy Equine Artificial Insemination Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Solution
        • 7.3.4.2.2. By Equine Type
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Equine Artificial Insemination Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Solution
        • 7.3.5.2.2. By Equine Type
        • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Equine Artificial Insemination Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
    • 8.2.2. By Equine Type (Sports/Racing, Recreation, Others)
    • 8.2.3. By Distribution Channel (Private, Public)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Equine Artificial Insemination Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Solution
        • 8.3.1.2.2. By Equine Type
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. Japan Equine Artificial Insemination Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Solution
        • 8.3.2.2.2. By Equine Type
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. India Equine Artificial Insemination Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Solution
        • 8.3.3.2.2. By Equine Type
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. Australia Equine Artificial Insemination Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Solution
        • 8.3.4.2.2. By Equine Type
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. South Korea Equine Artificial Insemination Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Solution
        • 8.3.5.2.2. By Equine Type
        • 8.3.5.2.3. By Distribution Channel

9. South America Equine Artificial Insemination Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
    • 9.2.2. By Equine Type (Sports/Racing, Recreation, Others)
    • 9.2.3. By Distribution Channel (Private, Public)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Equine Artificial Insemination Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Solution
        • 9.3.1.2.2. By Equine Type
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Argentina Equine Artificial Insemination Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Solution
        • 9.3.2.2.2. By Equine Type
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. Colombia Equine Artificial Insemination Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Solution
        • 9.3.3.2.2. By Equine Type
        • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Equine Artificial Insemination Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
    • 10.2.2. By Equine Type (Sports/Racing, Recreation, Others)
    • 10.2.3. By Distribution Channel (Private, Public)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Equine Artificial Insemination Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Solution
        • 10.3.1.2.2. By Equine Type
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Saudi Arabia Equine Artificial Insemination Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Solution
        • 10.3.2.2.2. By Equine Type
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. UAE Equine Artificial Insemination Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Solution
        • 10.3.3.2.2. By Equine Type
        • 10.3.3.2.3. By Distribution Channel
    • 10.3.4. Kuwait Equine Artificial Insemination Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Solution
        • 10.3.4.2.2. By Equine Type
        • 10.3.4.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Product Offerings
  • 14.3. Recent Developments
  • 14.4. Financials (As Reported)
  • 14.5. Key Personnel
  • 14.6. SWOT Analysis
    • 14.6.1. IMV Technologies SADIR
    • 14.6.2. Stallion A I Services Ltd
    • 14.6.3. Zoetis Inc
    • 14.6.4. Neogen Corp
    • 14.6.5. Zerlotti Genetics Ltd
    • 14.6.6. Erc S.r.o.
    • 14.6.7. CVS UK Ltd
    • 14.6.8. HOFFMAN A.I. BREEDERS INC.
    • 14.6.9. Continental Genetics, LLC
    • 14.6.10. Minitub GmbH

15. Strategic Recommendations

16. About Us & Disclaimer